{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,21]],"date-time":"2025-12-21T10:24:54Z","timestamp":1766312694316,"version":"3.37.3"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,6,30]],"date-time":"2023-06-30T00:00:00Z","timestamp":1688083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,6,30]],"date-time":"2023-06-30T00:00:00Z","timestamp":1688083200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Paroxysmal nocturnal hemoglobinuria (PNH) results from a mutation in the phosphatidylinositol glycan class-A gene which causes uncontrolled complement activation with resultant intravascular hemolysis and its sequelae. Eculizumab is a terminal complement inhibitor that blocks this complement activation and has revolutionized the treatment of PNH but comes with an enormous price which can have catastrophic health expenditure in low-middle income countries (LMIC) like Nepal. Here, we discuss the potential way forwards in the treatment of PNH in Nepal and other LMICs.<\/jats:p>","DOI":"10.1186\/s13023-023-02779-2","type":"journal-article","created":{"date-parts":[[2023,6,30]],"date-time":"2023-06-30T09:03:05Z","timestamp":1688115785000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Eculizumab for paroxysmal nocturnal haemoglobinuria: catastrophic health expenditure in Nepalese patients"],"prefix":"10.1186","volume":"18","author":[{"given":"Sugat","family":"Adhikari","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Surendra","family":"Sapkota","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6888-260X","authenticated-orcid":false,"given":"Suraj","family":"Shrestha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kshitiz","family":"Karki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anjan","family":"Shrestha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,6,30]]},"reference":[{"issue":"3","key":"2779_CR1","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1182\/blood.V6.3.270.270","volume":"6","author":"WH Crosby","year":"1951","unstructured":"Crosby WH. Historical review: Paroxysmal Nocturnal Hemoglobinuria: a Classic description by Paul Str\u00fcbing in 1882, and a bibliography of the Disease. Blood. 1951;6(3):270\u201384. https:\/\/doi.org\/10.1182\/blood.V6.3.270.270.","journal-title":"Blood"},{"issue":"18","key":"2779_CR2","doi-asserted-by":"publisher","first-page":"2804","DOI":"10.1182\/blood-2014-02-522128","volume":"124","author":"RA Brodsky","year":"2014","unstructured":"Brodsky RA. Paroxysmal nocturnal hemoglobinuria. Blood. 2014;124(18):2804\u201311. https:\/\/doi.org\/10.1182\/blood-2014-02-522128.","journal-title":"Blood"},{"issue":"12","key":"2779_CR3","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1056\/NEJMoa061648","volume":"355","author":"P Hillmen","year":"2006","unstructured":"Hillmen P, Young NS, Schubert J, et al. The complement inhibitor eculizumab in paroxysmal nocturnal hemoglobinuria. N Engl J Med. 2006;355(12):1233\u201343. https:\/\/doi.org\/10.1056\/NEJMoa061648.","journal-title":"N Engl J Med"},{"issue":"9665","key":"2779_CR4","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/S0140-6736(09)60001-5","volume":"373","author":"C Parker","year":"2009","unstructured":"Parker C. Eculizumab for paroxysmal nocturnal haemoglobinuria. Lancet. 2009;373(9665):759\u201367. https:\/\/doi.org\/10.1016\/S0140-6736(09)60001-5.","journal-title":"Lancet"},{"key":"2779_CR5","unstructured":"Shah N, Bhatt H. Paroxysmal nocturnal hemoglobinuria. StatPearls. StatPearls Publishing; 2021. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/32965963."},{"issue":"1","key":"2779_CR6","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/ejh.13059","volume":"101","author":"A R\u00f6th","year":"2018","unstructured":"R\u00f6th A, Maciejewski J, Nishimura JI, Jain D, Weitz JI. Screening and diagnostic clinical algorithm for paroxysmal nocturnal hemoglobinuria: Expert consensus. Eur J Haematol. 2018;101(1):3\u201311. https:\/\/doi.org\/10.1111\/ejh.13059.","journal-title":"Eur J Haematol"},{"issue":"157","key":"2779_CR7","doi-asserted-by":"publisher","first-page":"23","DOI":"10.31729\/jnma.425","volume":"44","author":"BP Paudyal","year":"2005","unstructured":"Paudyal BP, Zimmerman M, Karki A, Neupane H, Kayastha G. Paroxysmal nocturnal hemoglobinuria. JNMA J Nepal Med Assoc. 2005;44(157):23\u20135. https:\/\/doi.org\/10.31729\/jnma.425.","journal-title":"JNMA J Nepal Med Assoc"},{"issue":"2","key":"2779_CR8","doi-asserted-by":"publisher","first-page":"117","DOI":"10.4103\/0972-5229.175948","volume":"20","author":"GS Shrestha","year":"2016","unstructured":"Shrestha GS, Poudyal BS, Sedain G, Mahmud KI, Acharya N. Cerebral venous thrombosis presenting with intracerebral hemorrhage in a patient with paroxysmal nocturnal hemoglobinuria. Indian J Crit Care Med. 2016;20(2):117\u20139. https:\/\/doi.org\/10.4103\/0972-5229.175948.","journal-title":"Indian J Crit Care Med"},{"issue":"5","key":"2779_CR9","doi-asserted-by":"publisher","first-page":"e14902","DOI":"10.7759\/cureus.14902","volume":"13","author":"B Pokhrel","year":"2021","unstructured":"Pokhrel B, Gautam S, Khanal S, Pokhrel NB, Shrestha A. A rare and misdiagnosed Entity Paroxysmal Nocturnal Hemoglobinuria: a Case Report. Cureus. 2021;13(5):e14902. https:\/\/doi.org\/10.7759\/cureus.14902.","journal-title":"Cureus"},{"key":"2779_CR10","doi-asserted-by":"publisher","first-page":"106445","DOI":"10.1016\/j.ijscr.2021.106445","volume":"87","author":"K Bhusal","year":"2021","unstructured":"Bhusal K, Kadel PB, Bhandari K, et al. Popliteal artery thrombosis as a rare complication of paroxysmal nocturnal hemoglobinuria (PNH): a case report. Int J Surg Case Rep. 2021;87:106445. https:\/\/doi.org\/10.1016\/j.ijscr.2021.106445.","journal-title":"Int J Surg Case Rep"},{"issue":"234","key":"2779_CR11","doi-asserted-by":"publisher","first-page":"192","DOI":"10.31729\/jnma.5838","volume":"59","author":"A Acharya","year":"2021","unstructured":"Acharya A, Yogi P, Singh P, Bhattarai TR. Herlyn Werner Wunderlich Syndrome presenting with ischemic stroke due to suspected paroxysmal nocturnal hemoglobinuria: a Case Report. JNMA J Nepal Med Assoc. 2021;59(234):192\u20136. https:\/\/doi.org\/10.31729\/jnma.5838.","journal-title":"JNMA J Nepal Med Assoc"},{"issue":"11","key":"2779_CR12","doi-asserted-by":"publisher","first-page":"3441","DOI":"10.1182\/blood.V112.11.3441.3441","volume":"112","author":"R Kelly","year":"2008","unstructured":"Kelly R, Arnold L, Richards S, et al. Modification of the Eculizumab dose to successfully manage intravascular breakthrough hemolysis in patients with Paroxysmal Nocturnal Hemoglobinuria. Blood. 2008;112(11):3441\u20131. https:\/\/doi.org\/10.1182\/blood.V112.11.3441.3441.","journal-title":"Blood"},{"issue":"4","key":"2779_CR13","doi-asserted-by":"publisher","first-page":"e0194564","DOI":"10.1371\/journal.pone.0194564","volume":"13","author":"KT Swe","year":"2018","unstructured":"Swe KT, Rahman MM, Rahman MS, et al. Cost and economic burden of illness over 15 years in Nepal: a comparative analysis. PLoS ONE. 2018;13(4):e0194564. https:\/\/doi.org\/10.1371\/journal.pone.0194564.","journal-title":"PLoS ONE"},{"key":"2779_CR14","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s12962-020-00227-7","volume":"18","author":"CL Ranabhat","year":"2020","unstructured":"Ranabhat CL, Subedi R, Karn S. Status and determinants of enrollment and dropout of health insurance in Nepal: an explorative study. Cost Eff Resour Alloc. 2020;18:40. https:\/\/doi.org\/10.1186\/s12962-020-00227-7.","journal-title":"Cost Eff Resour Alloc"},{"key":"2779_CR15","unstructured":"GDP per capita (current US$) - Nepal. Accessed September 20., 2022. https:\/\/data.worldbank.org\/indicator\/NY.GDP.PCAP.CD?locations=NP."},{"issue":"4","key":"2779_CR16","doi-asserted-by":"publisher","first-page":"741","DOI":"10.33314\/jnhrc.v18i4.2392","volume":"18","author":"AK Thapa","year":"2021","unstructured":"Thapa AK, Pandey AR. National and Provincial estimates of Catastrophic Health expenditure and its determinants in Nepal. J Nepal Health Res Counc. 2021;18(4):741\u20136. https:\/\/doi.org\/10.33314\/jnhrc.v18i4.2392.","journal-title":"J Nepal Health Res Counc"},{"issue":"9388","key":"2779_CR17","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1016\/S0140-6736(03)14377-2","volume":"362","author":"K Xu","year":"2003","unstructured":"Xu K. Catastrophic health expenditure. Lancet. 2003;362(9388):997. https:\/\/doi.org\/10.1016\/S0140-6736(03)14377-2.","journal-title":"Lancet"},{"issue":"10","key":"2779_CR18","doi-asserted-by":"publisher","first-page":"760","DOI":"10.2471\/BLT.13.126615","volume":"92","author":"E Saito","year":"2014","unstructured":"Saito E, Gilmour S, Rahman MM, Gautam GS, Shrestha PK, Shibuya K. Catastrophic household expenditure on health in Nepal: a cross-sectional survey. Bull World Health Organ. 2014;92(10):760\u20137. https:\/\/doi.org\/10.2471\/BLT.13.126615.","journal-title":"Bull World Health Organ"},{"issue":"8","key":"2779_CR19","first-page":"612","volume":"80","author":"K Kawabata","year":"2002","unstructured":"Kawabata K, Xu K, Carrin G. Preventing impoverishment through protection against catastrophic health expenditure. Bull World Health Organ. 2002;80(8):612. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12219150.","journal-title":"Bull World Health Organ"},{"issue":"6","key":"2779_CR20","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1111\/ejh.13166","volume":"101","author":"T Devos","year":"2018","unstructured":"Devos T, Meers S, Boeckx N, et al. Diagnosis and management of PNH: review and recommendations from a belgian expert panel. Eur J Haematol. 2018;101(6):737\u201349. https:\/\/doi.org\/10.1111\/ejh.13166.","journal-title":"Eur J Haematol"},{"issue":"10","key":"2779_CR21","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1182\/blood.2019003812","volume":"137","author":"RA Brodsky","year":"2021","unstructured":"Brodsky RA. How I treat paroxysmal nocturnal hemoglobinuria. Blood. 2021;137(10):1304\u20139. https:\/\/doi.org\/10.1182\/blood.2019003812.","journal-title":"Blood"},{"issue":"12","key":"2779_CR22","doi-asserted-by":"publisher","first-page":"3188","DOI":"10.3324\/haematol.2020.261826","volume":"106","author":"AM Risitano","year":"2021","unstructured":"Risitano AM, Kulasekararaj AG, Lee JW, et al. Danicopan: an oral complement factor D inhibitor for paroxysmal nocturnal hemoglobinuria. Haematologica. 2021;106(12):3188\u201397. https:\/\/doi.org\/10.3324\/haematol.2020.261826.","journal-title":"Haematologica"},{"issue":"6","key":"2779_CR23","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1182\/blood-2018-09-876136","volume":"133","author":"JW Lee","year":"2019","unstructured":"Lee JW, Sicre de Fontbrune F, Wong Lee Lee L, et al. Ravulizumab (ALXN1210) vs eculizumab in adult patients with PNH naive to complement inhibitors: the 301 study. Blood. 2019;133(6):530\u20139. https:\/\/doi.org\/10.1182\/blood-2018-09-876136.","journal-title":"Blood"},{"issue":"10","key":"2779_CR24","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.1016\/j.bbmt.2020.05.024","volume":"26","author":"M Markiewicz","year":"2020","unstructured":"Markiewicz M, Drozd-Sokolowska J, Biecek P, et al. Allogeneic hematopoietic stem cell transplantation for Paroxysmal Nocturnal Hemoglobinuria: Multicenter Analysis by the polish adult Leukemia Group. Biol Blood Marrow Transplant. 2020;26(10):1833\u20139. https:\/\/doi.org\/10.1016\/j.bbmt.2020.05.024.","journal-title":"Biol Blood Marrow Transplant"},{"issue":"4","key":"2779_CR25","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1007\/s40620-022-01282-4","volume":"35","author":"HS Nga","year":"2022","unstructured":"Nga HS, Palma LMP, Ernandes Neto M, Modelli de Andrade LG. Eculizumab in low-middle income countries: how much does a life cost? J Nephrol. 2022;35(4):1255\u20137. https:\/\/doi.org\/10.1007\/s40620-022-01282-4.","journal-title":"J Nephrol"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-023-02779-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-023-02779-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-023-02779-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,30]],"date-time":"2023-06-30T09:03:39Z","timestamp":1688115819000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-023-02779-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,30]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2779"],"URL":"https:\/\/doi.org\/10.1186\/s13023-023-02779-2","relation":{},"ISSN":["1750-1172"],"issn-type":[{"type":"electronic","value":"1750-1172"}],"subject":[],"published":{"date-parts":[[2023,6,30]]},"assertion":[{"value":"12 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"None to declare.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"172"}}